![What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH](https://www.trilogywriting.com/wp-content/uploads/2017/07/33.-Image-1.jpg)
What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH
![Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d763732d-acff-446e-872e-e81d6e44f06f/gr1_lrg.jpg)
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine
![Clinical Protocol and subjects in the Phase I safety trial: (A) Outline... | Download Scientific Diagram Clinical Protocol and subjects in the Phase I safety trial: (A) Outline... | Download Scientific Diagram](https://www.researchgate.net/publication/325047665/figure/fig1/AS:624423958740993@1525885681568/Clinical-Protocol-and-subjects-in-the-Phase-I-safety-trial-A-Outline-of-the-clinical.png)
Clinical Protocol and subjects in the Phase I safety trial: (A) Outline... | Download Scientific Diagram
![Procedure, scope and objectives of clinical studies. Phase I: Here, the... | Download Scientific Diagram Procedure, scope and objectives of clinical studies. Phase I: Here, the... | Download Scientific Diagram](https://www.researchgate.net/profile/Johannes-Fritsch-3/publication/280577359/figure/fig2/AS:614170005360640@1523440948246/Procedure-scope-and-objectives-of-clinical-studies-Phase-I-Here-the-safety-and-dosage.png)
Procedure, scope and objectives of clinical studies. Phase I: Here, the... | Download Scientific Diagram
![1 The phases of clinical trial research. Clinical trials pass through a... | Download Scientific Diagram 1 The phases of clinical trial research. Clinical trials pass through a... | Download Scientific Diagram](https://www.researchgate.net/profile/Andrea-Coravos/publication/340365409/figure/fig2/AS:920224400416768@1596410002454/The-phases-of-clinical-trial-research-Clinical-trials-pass-through-a-series-of-phases-as.png)
1 The phases of clinical trial research. Clinical trials pass through a... | Download Scientific Diagram
![Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e7d31c91-9c6a-4ecc-87eb-2074454af216/gr1a.jpg)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
![Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs41231-019-0050-7/MediaObjects/41231_2019_50_Fig1_HTML.png)
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text
![PDF] Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug PDF] Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug](https://d3i71xaburhd42.cloudfront.net/f3aedb5d20e731efe213af1f3733f00ec267e1a6/6-Figure3-1.png)